Literature DB >> 3093395

Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.

S G Silverberg, M Haukkamaa, H Arko, C G Nilsson, T Luukkainen.   

Abstract

Levonorgestrel-releasing intrauterine devices (IUD) were inserted in 92 women. Endometrial biopsies were taken between 3 months and 7 years after these insertions. Intrauterine release of levonorgestrel resulted in endometrial glandular atrophy and decidualized stroma. Inflammation and necrosis were also seen as local signs of IUD use. The biopsies were similar regardless of the duration of IUD use. Endometrial morphology returned to normal in biopsy specimens taken 1-3 months after IUD removal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093395     DOI: 10.1097/00004347-198609000-00005

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  21 in total

Review 1.  Fortnightly review. Medical management of menorrhagia.

Authors:  A Prentice
Journal:  BMJ       Date:  1999-11-20

2.  The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology.

Authors:  V Phillips; C T Graham; S Manek; W G McCluggage
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

3.  Medical management of menorrhagia.

Authors:  A Prentice
Journal:  West J Med       Date:  2000-04

4.  Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy.

Authors:  P Lähteenmäki; M Haukkamaa; J Puolakka; U Riikonen; S Sainio; J Suvisaari; C G Nilsson
Journal:  BMJ       Date:  1998-04-11

Review 5.  A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.

Authors:  F Sturridge; J Guillebaud
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

Review 6.  Levonorgestrel IUD: is there a long-lasting effect on return to fertility?

Authors:  Erin Dinehart; Ruth B Lathi; Lusine Aghajanova
Journal:  J Assist Reprod Genet       Date:  2019-11-11       Impact factor: 3.412

7.  Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression.

Authors:  Annelie Tjernlund; Ann M Carias; Sonia Andersson; Susanna Gustafsson-Sanchez; Maria Röhl; Pernilla Petersson; Andrea Introini; Thomas J Hope; Kristina Broliden
Journal:  Biol Reprod       Date:  2015-01-14       Impact factor: 4.285

8.  Levonorgestrel hormone releasing intrauterine system (Mirena) as a contraceptive in egg donors: case report.

Authors:  C Kailasam; V Akande; U D Gordon
Journal:  J Assist Reprod Genet       Date:  2005-03       Impact factor: 3.412

9.  Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).

Authors:  Ussanee S Sangkomkamhang; Pisake Lumbiganon; Porjai Pattanittum
Journal:  Cochrane Database Syst Rev       Date:  2020-11-23

10.  Malignant neoplasms of decidual origin (deciduosarcomas) induced by estrogen-progestin-releasing intravaginal devices in rabbits.

Authors:  B C Zook; I Spiro; R Hertz
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.